Skip to main content
Pre-Market BriefFriday, November 6, 2026 at 8:20 AM ET

Pre-market movers Nov 6, 2026: MRNA, GOOGL, QCOM

US stock futures were higher after Thursday’s risk-off slide as traders look for stability in AI-linked areas, while $MRNA lifted its 2026 outlook on newer vaccine demand.

Live intraday price action for $MRNA via TradingView. Market data shown for context only. It is not ZORO performance.

FRIDAY’S TOP READS

  • Futures point higher after Thursday’s sharp selloff, with traders watching whether an AI-linked rebound can hold.
  • Moderna raised its 2026 revenue growth outlook as demand trends improve for newer vaccines.

Overnight

Futures try to regroup after a risk-off hit

US stock futures were higher in premarket trading after Thursday’s broad risk-off session, which CNBC said was the worst one-day decline in more than a year. The early bounce now hinges on one test: whether AI-linked areas can stabilize after steep de-risking. With no overnight market data provided here, attention is shifting to positioning and company-specific catalysts rather than a single macro datapoint. For more context on recent rotation pressure, see yesterday’s pre-market movers.

Most discussed

Moderna raises its 2026 growth outlook as newer vaccines gain traction

Moderna $MRNA led premarket chatter after it raised its 2026 revenue growth forecast. MarketWatch reported Moderna now expects 2026 revenue growth of 15% to 25%, up from prior guidance of up to 10%. CNBC also pointed to improving uptake trends for the company’s newer vaccine portfolio as the driver behind the outlook change. The immediate question for traders is how revised expectations reshape sentiment following Thursday’s selloff.

Today’s focus stays on guidance trajectory and demand commentary rather than a single product headline. Risk appetite across the broader market could influence how investors interpret Moderna’s updated range, particularly if AI-linked areas remain volatile. Those looking to pressure-test process over narrative often compare similar setups with a free ai trading bot to ensure entry and exit rules are consistent. Prices and performance metrics were not provided in the available reference data.

Subscribe to continue reading your article

Free Forever. Enter your email to unlock the full brief and get it every trading morning before the open.

Already a subscriber?

You are subscribing to the ZORO Pre-Market Brief. No brokerage connection required, and ZORO never holds your funds.

The Pre-Market Brief is generated with AI from published news reports and market data and may contain errors or delays. It is for information only and is not investment, legal or tax advice, or a recommendation or offer to buy or sell any security. Examples are hypothetical. ZORO does not provide personalized advice. You choose the rules you run and are responsible for the trades in your account, and your funds stay with your broker. Automated trading adds risks such as connectivity failures, latency and partial fills, and does not remove market risk. Past performance is not indicative of future results, and trading involves risk of loss. ZORO, its team and traders on the platform may hold positions in securities mentioned.

Past Briefs

Daily archive